Profil
Oliver Buck is the founder of OncoBeta GmbH.
He is currently a Trustee at the International Centers for Precision Oncology Foundation and a Member-Supervisory Board at ITM Isotope Technologies Munich SE.
Previously, he served as a Non-Independent Non-Executive Director at Telix Pharmaceuticals Ltd. from 2017 to 2022.
Mr. Buck graduated from Technische Universität München.
Aktiva positioner av Oliver Buck
| Företag | Position | Start |
|---|---|---|
ITM Isotope Technologies Munich SE
ITM Isotope Technologies Munich SE Pharmaceuticals: MajorHealth Technology Manufactures and supplies medical radioisotopes for diagnosis and targeted treatment of various cancer indications | Direktör/Styrelseledamot | 2012-01-01 |
International Centers for Precision Oncology Foundation | Direktör/Styrelseledamot | - |
Tidigare kända positioner av Oliver Buck
| Företag | Position | Slut |
|---|---|---|
| TELIX PHARMACEUTICALS LIMITED | Direktör/Styrelseledamot | 2022-05-18 |
OncoBeta GmbH
OncoBeta GmbH Medical SpecialtiesHealth Technology Operates as a medical device and radiochemical company | Grundare | - |
Oliver Bucks utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 5 |
|---|---|
Technische Universität München
Technische Universität München Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Telix Pharmaceuticals Ltd.
Telix Pharmaceuticals Ltd. BiotechnologyHealth Technology Operates as a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutic and diagnostic radiopharmaceuticals | Health Technology |
OncoBeta GmbH
OncoBeta GmbH Medical SpecialtiesHealth Technology Operates as a medical device and radiochemical company | Health Technology |
International Centers for Precision Oncology Foundation | |
ITM Isotope Technologies Munich SE
ITM Isotope Technologies Munich SE Pharmaceuticals: MajorHealth Technology Manufactures and supplies medical radioisotopes for diagnosis and targeted treatment of various cancer indications | Health Technology |
















